UnitedHealth reported Q2-FY25 revenue of $111.6 billion, up 12.9% YoY, driven by UnitedHealthcare and Optum divisions. Learn ...

DOJ probes, vertical integration risks, shaky earnings quality, and fading investor trust despite strong headline profits ...

Now, DeVeydt—also former chairman and CEO of Surgery Partners and former CFO at Anthem (now Elevance)—will need to play a ...

UnitedHealth Group Incorporated stock is down 53% YTD. Click for why its low valuations, resilient growth, and AI-driven ...

While use of artificial intelligence in health insurance remains controversial, UnitedHealth Group is full speed ahead on AI.

Investing.com - UBS has reiterated its Buy rating and $330.00 price target on UnitedHealth Group (NYSE: UNH) following an investor lunch with the company’s management team. The stock, currently ...

Bernstein SocGen Group lowered its price target on UnitedHealth Group (NYSE: UNH) to $337.00 from $377.00 on Monday, while maintaining an Outperform rating on the healthcare giant. The stock, ...

On Tuesday, UnitedHealth said it expects adjusted earnings of at least $16 a share in 2025. That compares with consensus ...

UnitedHealth Group provided a full-year profit forecast on Tuesday after suspending its prior outlook in May, revealing ...

UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical ...

UnitedHealth Group said on Thursday it will replace its finance chief John Rex with an external hire, Wayne DeVeydt, adding ...

UnitedHealth delivered disappointing second-quarter earnings and went conservative with its 2025 forecast as soaring medical ...